azithromycin SR (Zithromax; compound: CP-62,993)
A0661102
Phase 3 small_molecule completed
Quick answer
azithromycin SR (Zithromax; compound: CP-62,993) for Bronchitis, Chronic is a Phase 3 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Bronchitis, Chronic
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed